$VERA stock has now fallen 8% today, according to our price data from Polygon. There has been approximately $20,312,374 of trading volume.
It has been the 186th most-searched ticker on Quiver Quantitative over the last day, out of 13,451 total tickers searched.
Here is what we see in our data on $VERA (you can track the company live on Quiver's $VERA stock page):
$VERA Insider Trading Activity
$VERA insiders have traded $VERA stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $VERA stock by insiders over the last 6 months:
- MARSHALL FORDYCE (PRESIDENT AND CEO) has made 0 purchases and 12 sales selling 123,126 shares for an estimated $5,059,331.
- SEAN GRANT (CHIEF FINANCIAL OFFICER) sold 4,949 shares for an estimated $207,778
- JOSEPH R YOUNG (SVP, FINANCE, CHIEF ACCT OFFCR) sold 3,117 shares for an estimated $130,863
- DAVID LEE JOHNSON (Chief Operating Officer) sold 2,579 shares for an estimated $108,276
- WILLIAM D. TURNER (Chief Regulatory Officer) sold 2,187 shares for an estimated $91,818
- ROBERT BRENNER (Chief Medical Officer) sold 2,151 shares for an estimated $90,307
- LAURENCE MATTHEW SKELTON (Chief Commercial Officer) sold 1,582 shares for an estimated $66,418
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$VERA Hedge Fund Activity
We have seen 123 institutional investors add shares of $VERA stock to their portfolio, and 79 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HOLOCENE ADVISORS, LP removed 1,307,393 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $50,864,124
- DEEP TRACK CAPITAL, LP added 1,284,932 shares (+45.5%) to their portfolio in Q1 2026, for an estimated $49,990,279
- EVERSEPT PARTNERS, LP removed 899,018 shares (-29.3%) from their portfolio in Q1 2026, for an estimated $34,976,295
- PRICE T ROWE ASSOCIATES INC /MD/ removed 887,946 shares (-16.3%) from their portfolio in Q1 2026, for an estimated $34,545,539
- VESTAL POINT CAPITAL, LP added 818,159 shares (+148.8%) to their portfolio in Q1 2026, for an estimated $31,830,475
- TRI LOCUM PARTNERS LP removed 805,689 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $31,345,330
- STATE STREET CORP added 687,038 shares (+25.7%) to their portfolio in Q1 2026, for an estimated $26,729,213
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$VERA Analyst Ratings
Wall Street analysts have issued reports on $VERA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 07/07/2026
To track analyst ratings and price targets for $VERA, check out Quiver Quantitative's $VERA forecast page.
$VERA Price Targets
Multiple analysts have issued price targets for $VERA recently. We have seen 7 analysts offer price targets for $VERA in the last 6 months, with a median target of $78.0.
Here are some recent targets:
- Arthur He from HC Wainwright & Co. set a target price of $125.0 on 07/08/2026
- Vamil Divan from Guggenheim set a target price of $76.0 on 07/08/2026
- Laura Chico from Wedbush set a target price of $35.0 on 07/08/2026
- Ritu Baral from TD Cowen set a target price of $78.0 on 07/08/2026
- Dina Ramadane from B of A Securities set a target price of $70.0 on 07/07/2026
- Gavin Clark-Gartner from Evercore ISI Group set a target price of $91.0 on 05/15/2026
- Andy Chen from Wolfe Research set a target price of $88.0 on 03/11/2026
You can track data on $VERA on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
